[Overview on pulmonary rehabilitation].

Übersicht zur pneumologischen Rehabilitation.
Breathing exercises Education Exercise training Physical performance Quality of life

Journal

Der Pneumologe
ISSN: 1613-5636
Titre abrégé: Pneumologe (Berl)
Pays: Germany
ID NLM: 101233663

Informations de publication

Date de publication:
2022
Historique:
accepted: 14 12 2021
pubmed: 25 1 2022
medline: 25 1 2022
entrez: 24 1 2022
Statut: ppublish

Résumé

Pulmonary rehabilitation (PR) is an evidence-based multidisciplinary treatment for patients with chronic respiratory diseases. The indications for PR prescription are given if there is a rehabilitation capability, a need for rehabilitation and a beneficial rehabilitation prognosis. The aims of PR are to reduce symptoms and to improve the quality of life and the patients' physical capacity. The effectiveness of PR is well-proven for patients with chronic obstructive pulmonary disease (COPD) at the highest level of evidence and for non-COPD patients with an increasing level of evidence based on randomized controlled trials and meta-analyses. The treatment content of PR is individually adapted to the patients' needs by a multimodal and multidisciplinary treatment team. To maintain the rehabilitation benefits of PR there is the possibility to participate in outpatient follow-up programs as well as to use digital technologies.

Identifiants

pubmed: 35069062
doi: 10.1007/s10405-021-00431-z
pii: 431
pmc: PMC8764642
doi:

Types de publication

English Abstract Journal Article Review

Langues

ger

Pagination

130-141

Informations de copyright

© The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022.

Références

Int J Chron Obstruct Pulmon Dis. 2018 Nov 23;13:3831-3836
pubmed: 30538444
Lancet Respir Med. 2018 Jan;6(1):19-28
pubmed: 29248433
JAMA. 2020 May 12;323(18):1813-1823
pubmed: 32396181
Pneumologie. 2017 Dec;71(12):e3
pubmed: 30406626
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
ERJ Open Res. 2021 May 31;7(2):
pubmed: 34095290
Thorax. 2010 Jan;65(1):7-13
pubmed: 19703824
Dtsch Arztebl Int. 2021 Jan 22;118(3):23-30
pubmed: 33759752
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Thorax. 2014 Feb;69(2):181-2
pubmed: 23945168
Eur J Phys Rehabil Med. 2021 Oct;57(5):850-857
pubmed: 34749491
Eur Respir J. 2017 Mar 15;49(3):
pubmed: 28298398
Chest. 2011 Sep;140(3):744-752
pubmed: 21493697
ERJ Open Res. 2021 Aug 31;7(3):
pubmed: 34471633
Pneumologie. 2020 Aug;74(8):496-504
pubmed: 32583378
Respir Med. 2017 Aug;129:140-144
pubmed: 28732821
Chest. 2007 May;131(5 Suppl):4S-42S
pubmed: 17494825
Eur Respir J. 2020 Aug 13;:
pubmed: 32817258
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD005305
pubmed: 21975749
Respir Med. 2017 Sep;130:98-101
pubmed: 29206641
Respir Med. 2020 Apr - May;165:105930
pubmed: 32174451
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910

Auteurs

Daniela Leitl (D)

Forschungsinstitut für pneumologische Rehabilitation, Schön Klinik Berchtesgadener Land, Malterhöh 1, 83471 Schönau am Königssee, Deutschland.
Pneumologische Rehabilitation, Deutsches Zentrum für Lungenforschung, Philipps-Universität Marburg, Marburg, Deutschland.

Rainer Glöckl (R)

Forschungsinstitut für pneumologische Rehabilitation, Schön Klinik Berchtesgadener Land, Malterhöh 1, 83471 Schönau am Königssee, Deutschland.
Pneumologische Rehabilitation, Deutsches Zentrum für Lungenforschung, Philipps-Universität Marburg, Marburg, Deutschland.

Classifications MeSH